Medicinal chemistry – Page 59
-
Business
EU regulator calls for generic drug suspensions
The EMA wants hundreds of formulations off the market after identifying systematic fraud in a major Indian contract clinical research organisation
-
NewsBillion dollar package unveiled to fight antibiotic resistance
President Obama wants to almost double US funding to fight antibiotic resistant bacteria in 2016
-
News
Ebola vaccine shown to be safe in humans
GlaxoSmithKline vaccine will now be trialled in Liberia
-
News
BPA use poses 'no health risks', says EU
A European Food Safety Authority evaluation has found the use of BPA in plastics does not cause harm
-
NewsRoadmap to fast track Ebola vaccine development
Expert panel recommends developing multiple vaccines and targeting at risk groups
-
NewsVeterinary painkiller threatens Europe's vultures
Drugs that almost drove vultures to extinction on the Indian sub-continent are now being used in Europe
-
ResearchInfrared offers odds on skin cancer spreading
Identifying melanomas that have not metastasised could help patients avoid unnecessary and unpleasant additional treatment
-
FeatureMapping the mosquito
Uncovering how mosquitoes sniff out their human victims may lead to new tools to conquer malaria and dengue fever. Emma Davies reports
-
ResearchNew antibiotic could treat infection while dodging resistance problems
Technique to tap huge unexplored reservoir of natural products in soil microorganisms finds promising compound
-
-
-
ResearchSmart nanoparticles take aim at cancer cells
Intranuclear radiosensitisation technique intensifies radiotherapy to drive tumour regression in mouse model
-
-
NewsAntimicrobial resistance will kill 300 million by 2050 without action
UK report says resistance will cost global economy $100 trillion
-
BusinessMerck & Co to buy antibiotics specialist Cubist
Pharma giant remains committed to $9.5bn deal despite key Cubist patents being invalidated by court ruling
-
ResearchSunlight activates radical approach to dengue eradication
Mosquito larvae degraded by iron oxide catalysts supported on floating blocks
-
News
Tufts’ $2.6bn drug development figure questioned
Details sought about how university determined cost of bringing a drug to market jumped 145% since 2003
-
NewsEbola vaccine passes first safety hurdle
Researchers hope to begin larger trials of its effectiveness in west Africa soon
-
PodcastCannabicyclohexanol
Used to make synthetic cannabis, cannabicyclohexanol may be more risky than its non-synthetic counterpart
-
OpinionProgress at the pace of the slowest
Chemistry is rarely the rate-limiting process in getting a drug to market, says Derek Lowe